NKGen Biotech, Inc. Common Stock
Compare this stock
NKGN Stock Report Card
$
10%
Performance
Score:
10/100
NKGN returned -53.87% in the last 12 months. Based on SPY's performance of 9.73%, its performance is below average giving it a score of 10 of 100.
Volatility
Score:
10/100
NKGN has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.
NKGen Biotech, Inc. Common Stock Summary
Nasdaq / NKGN
Healthcare
Biotechnology
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
NKGN scored poorly on our reportcard. Here are some similar companies and how they performed.
